Dilaudid (Hydromorphone)

hydromorphone hydrochloride 2 mg tablet, 20 · ORAL · PBS code 5115F

RESTRICTED

What it costs

AU$6.13 PBS-determined price per 20 units

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

• First listed on the PBS: 2001-11-01.
• Repeats: 0.
• PBS program: GE.

Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Severe pain

Patient must have had or would have inadequate pain management with maximum tolerated doses of non-opioid and other opioid analgesics; or

Patient must be unable to use non-opioid and other opioid analgesics due to contraindications or intolerance.

Sponsor: Mundipharma Pty Limited ABN 87 081 322 509

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.